VERA SCHEDULE 13G/A: SEC filing
T. Rowe Price Associates, Inc.
Filed with the SEC on · accession 0000080255-26-000722
VERA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -4.0% by the first close after the filing.
Summary of the filing
T. Rowe Price Associates, Inc. filed an amended Schedule 13G reporting beneficial ownership of 2,753,148 shares of Vera Therapeutics, Inc. common stock, representing 3.8% of the class, as of September 30, 2026.
Key details
How VERA stock reacted
Close before
$28.10
Nov 13, 2026
First close after
-4.02%
$26.97
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for VERA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VERA?
Click hereFrequently asked questions
What did VERA file with the SEC on Nov 16, 2026?
VERA filed a SCHEDULE 13G/A (SEC filing). T. Rowe Price Associates, Inc. filed an amended Schedule 13G reporting beneficial ownership of 2,753,148 shares of Vera Therapeutics, Inc. common stock, representing 3.8% of the class, as of September 30, 2026.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did VERA stock react to this filing?
VERA closed at $28.10 before the filing and $26.97 on Nov 16, 2026 (-4.02%).
Other VERA SEC filings
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G · SEC filingNov 10, 2026
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingNov 5, 2026
- 8-K · Fda approvalSep 15, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · SEC filingAug 10, 2026
- 10-Q · SEC filingAug 10, 2026
- 8-K · SEC filingJul 9, 2026
Get alerts when VERA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days